ScholarWorks@Korea University: Jung, Sung Woo

Detailed Information

Jung, Sung Woo (정성우)

College of Medicine (Department of Medical Science)

Research Area

Tel 산6022
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Helicobacter pylori:10||drug therapy:3||eradication:3||concomitant therapy:3||hepatocellular carcinoma:2||combination:2||INFECTION:2||administration and dosage:2||Gastrointestinal hemorrhage:2||Triple therapy:2||STRAINS:2||incidence:2||mortality:2||Eradication rate:2||amoxicillin:2||proton pump inhibitor:2||Endoscopic mucosal resection:2||treatment:1||bismuth salts:1||sequential therapy:1||Jejunal polyp:1||iatrogenic gastric ulcer:1||sentinel node:1||antithrombotics:1||recurrence:1||Therapeutic embolization:1||Ileal gastrointestinal stromal tumor:1||Colonoscopy:1||Cancer screening:1||Iron Therapy:1||ASSOCIATION:1||peptic ulcer perforation:1||gastroesophageal reflux:1||Bismuth:1||CAGA:1||제균율:1||삼제요법:1||Pancreatic stellate cells:1||drug administration schedule:1||substaging:1||Functional gastrointestinal disorder:1||colonoscopy:1||poor bowel preparation:1||Sedative endoscopy:1||Enterohepatic fistula:1||Gastric cancer:1||CAG PATHOGENICITYISLAND:1||bleeding:1||prevalence:1||retreatment:1||Ethanol injection:1||Erosive esophagitis:1||Irritable bowel syndrome:1||resistance:1||Inflammatory bowel disease:1||early gastric cancer:1||Pain:1||Endoscopic resection:1||highrisk findings:1||Enterolith:1||DUODENALULCER:1||INTERLEUKIN1 POLYMORPHISMS:1||Carotid intimamedia thickness:1||CLINICALRELEVANCE:1||Endoscopic treatment:1||Abdominal obesity:1||stage:1||Intestinal surgery:1||infrequent bowel movement:1||Malignant biliary obstruction:1||Sedation:1||cyclooxygenase2 inhibitor:1||tuberculosis:1||Liver cirrhosis:1||Gastrointestinal endoscopy:1||quadruple therapy:1||Cirrhosis:1||Nonalcoholic fatty liver disease:1||헬리코박터 파이로리:1||Peptic ulcer:1||HMGCoA reductase inhibitor:1||Common bile duct stone:1||Endoscopic retrograde cholangiopancreatography:1||Cholangitis:1||Heterotopic gastric mucosa:1||Diagnostic delay:1||constipation:1||endoscopic resection:1||malignant duodenal obstruction:1||metal stent:1||Drug delivery systems:1||polypectomy:1||Periampullary Diverticulitis:1||Survival:1||Tumor necrosis factoralpha:1||Hepatic encephalopathy:1||CYTOTOXIN PRODUCTION:1||temporal trend:1||postoperative mortality:1||prediction model:1||GASTRODUODENAL DISEASES:1||PROMOTING GENE:1||Nonbleeding:1||Synergism:1||Hepatocellular carcinoma:1||Recurrence:1||prognosis:1||Recurrent jejunal intussusception:1||Crohn's disease:1||laparoscopy:1||visible light:1||Endoscopic submucosal dissection:1||Gastric neoplasm:1||bleeding ulcer:1||cardiovascular events:1||surveillance colonoscopy:1||combination drug therapy:1||simvastatin:1||infection:1||Propofol:1||Gastric adenoma:1||Small Bowel:1||VACA:1||population:1||healthcare utilization:1||secondline therapy:1||DUPA:1||INFLAMMATION:1||Treatment:1||Duodenal bleeding:1||Causality:1||Sleep:1||Ulcerative colitis:1||Atelectasis:1||Antibacterial agents:1||Liposomes:1||Colon adenoma:1||Pseudomelanosis:1||GASTRICCANCER:1||antidepressant:1||peptic ulcer:1||proton pump inhibitors:1||PATHOGENESIS:1||PPAR gamma agonist:1||Risk assessment:1||Mortality:1||bowel habits:1||fluorescein:1||Fatty acids:1||Lemmel's Syndrome:1||gastric cancer:1||Chemotherapy:1||Socioeconomic status:1||Gastrointestinal stromal tumor:1||Bleeding:1||GENOTYPES:1||Amitriptyline:1||irritable bowel syndrome:1||tianeptine:1||Peptic ulcer hemorrhage:1||Disease management:1||Fatty liver:1||RISK:1||Risk factor:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE